Detalhe da pesquisa
1.
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment.
Hematol Oncol
; 38(2): 189-196, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31891213
2.
Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert Board.
Support Care Cancer
; 27(11): 4083-4090, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30778756
3.
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.
Eur J Haematol
; 96(4): 344-51, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26018238
4.
An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms.
Ann Hematol
; 94(5): 771-7, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25743685
5.
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.
Am J Hematol
; 90(5): E80-5, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25653205
6.
Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.
Ann Hematol
; 93(8): 1413-20, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24647684
7.
Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study.
Ann Hematol
; 92(1): 25-32, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22983750
8.
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity?
J Clin Med
; 11(9)2022 May 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35566719
9.
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches.
Expert Opin Drug Saf
; 19(2): 187-204, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32005072
10.
Real-life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile.
Am J Hematol
; 89(5): 565, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24458879
11.
Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.
Cancer Commun (Lond)
; 43(7): 844-849, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37337406
12.
Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.
Cancer Med
; 4(12): 1789-97, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26376955
13.
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database.
J Clin Oncol
; 31(21): 2671-7, 2013 Jul 20.
Artigo
Inglês
| MEDLINE | ID: mdl-23796988
14.
HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: Evidence and open questions.
World J Gastrointest Oncol
; 4(3): 46-53, 2012 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22468183
15.
Azacitidine for the treatment of lower risk myelodysplastic syndromes : a retrospective study of 74 patients enrolled in an Italian named patient program.
Cancer
; 116(6): 1485-94, 2010 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20151429
16.
Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma.
Leuk Lymphoma
; 49(9): 1745-51, 2008 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-18798109
17.
Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro.
Eur J Neurosci
; 16(4): 584-92, 2002 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-12270034